Recent Developments in Ovarian and Endometrial Cancers Stir Excitement Among Clinicians

Despite advanced ovarian and endometrial cancer still being accompanied by a poor prognosis and remaining largely difficult-to-treat diseases, optimism among clinicians has steadily ramped up in recent years with the development of multiple new promising agents and treatment regimens.

Related Keywords

United States ,American ,Ursulaa Matulonis ,Matthewa Powell ,Bhavana Pothuri ,International Federation Of Gynecology ,American Society Of Clinical Oncology ,Onclive Peer Exchange ,Onclive Peer ,Clinical Oncology ,International Federation ,Checkpoint Inhibitors ,Endometrial Cancer ,New England Journal ,Ovarian Cancer ,Gynecologic Oncology ,Parp Inhibitors ,Immune Checkpoint Inhibitors ,